In conclusion, this review was created to help address the common challenges of insulin initiation faced by patients and healthcare providers, to help optimize the use of basal insulin, and thereby improve glycaemic control in insulin‐naïve patients with T2DM. This evidence concerns the gene INS and type 2 diabetes mellitus.